跳至主要内容
临床试验/NCT01402128
NCT01402128已完成2 期

The Effect of Barley Beta-glucan on Serum Lipids and Body Weight

Chonbuk National University Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年6月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
80
试验地点
1
主要终点
Changes in Body Fat Mass(kg)

研究概览

简要总结

Barley, like oats, is a rich source of the soluble fibre β-glucan, which has been shown to significantly lower LDL-cholesterol (LDL-C). However, barley foods have been less widely studied.

详细描述

This study investigated whether the supplementation of barley β-glucan is reduce the visceral fat as well as the serum low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in mildly hypercholesterolemic subjects. In a 12 week double-blind, controlled study, subjects were randomized to one of treatment group(3.0g/day as β-glucan) or placebo group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •an age from 19 to 70 years,
  • •a BMI(Body Mass Index) >23 kg/m^2,
  • •an LDL-C(Low Density Lipoprotein-cholesterol) concentration between 110 and 250 mg/dL

排除标准

  • •they had heart disease, liver or kidney disease, food allergies, daily exercise habits, a body weight increase or decrease >10 kg in the previous 3 months, irregular lifestyle habits
  • •they took medication and functional foods known to affect lipid metabolism.

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo for 12 weeks

干预措施: Placebo (Dietary Supplement)

Barley beta-glucan(3.0g)

Experimental

Barley beta-glucan(3.0g/day) for 12 weeks

干预措施: Barley beta-glucan(3.0g) (Dietary Supplement)

结局指标

主要结局

Changes in Body Fat Mass(kg)

时间窗: 12 weeks

Body fat mass(kg) was measured in study visit 1(0 week) and visit 3(12 week).

Changes in Percent Body Fat(%)

时间窗: 12 weeks

Percent body fat(%) was measured in study visit 1(0 week) and visit 3(12 week).

次要结局

  • Changes in Visceral Adipose Tissue(12 weeks)
  • Changes in LDL-C (LDL Low Density Lipoprotein-cholesterol)(12 weeks)
  • Changes in HDL-C(High Density Lipoprotein-cholesterol)(12 weeks)
  • Changes in Total Cholesterol(12 weeks)
  • Changes in Triglyceride(12 weeks)
  • Changes in FFA(Free Fatty Acid)(12 weeks)
  • Changes in Apo-A1(Apolipoprotein A1)(12 weeks)
  • Changes in Apo-B(Apolipoprotein B)(12 weeks)
  • Changes in Subcutaneous Adipose Tissue(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

研究点 (1)

Loading locations...

相似试验